IR vs JUNS · P/E 49, rev $3.90B vs rev $21.8K
Ingersoll Rand Inc (IR) versus Jupiter Neurosciences, Inc. Common Stock (JUNS) — a side-by-side from cached financials, not a winner call.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Jupiter Neurosciences, Inc. Common Stock (JUNS) is a biotechnology company listed on NASDAQ.
Latest reported IR revenue for 2026-06-30 was $3.90B. Net income was $448.9M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Latest reported JUNS revenue for 2025-12-31 was $21.8K. Net income was -$8.6M. JUNS currently screens at market cap $10.0M.
IR currently screens at market cap $28.27B and trailing P/E 48.8. JUNS currently screens at market cap $10.0M.
Not investment advice. Open the IR and JUNS stock pages for the full models.
Not investment advice.